Cargando...
Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations
Gout is a common rheumatic condition, with increasing prevalence in recent decades. The mainstay of treatment for gout is oral urate-lowering therapy (ULT), typically with xanthine oxidase inhibitors (XOIs). Unfortunately, a proportion of patients have persistent gout that is refractory to ULT. Pegl...
Guardado en:
| Publicado en: | Ther Adv Drug Saf |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703101/ https://ncbi.nlm.nih.gov/pubmed/29204266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098617727714 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|